Company Quick10K Filing
Brighthouse Life Insurance
10-Q 2020-09-30 Filed 2020-11-09
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-12
10-K 2019-12-31 Filed 2020-03-05
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-05
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-22
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-03-25
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-22
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-10
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-22
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-23
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-12
10-K 2009-12-31 Filed 2010-03-24
8-K 2019-02-05

Brighthouse Life Insurance Financials

BHL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-12-312014-03-312014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,2209647451,2639681,3168951,2767461,8431,2068277317821,3831,4722,2982,1171,8882,1292,2331,3881,3631,4111,7171,6333,4943,1443,4273,720
Accounts Receivable
Inventory
PP&E519528503500482540708729
Assets165,482163,771171,771179,092176,694183,659184,796190,434188,039190,664205,863212,322207,522203,176202,362209,173214,837215,407199,273200,016210,663210,940212,045207,226204,579204,968195,830205,026209,908214,847
Accounts Payable
Long-Term Debt7,4103,9503,8573,7383,6413,5823,3503,0832,2511,7909289219118498368268178088048015350464340237434845845845
Liabilities156,913153,379161,598169,517166,409173,017174,047179,634179,251181,304193,857199,737196,144191,383190,799194,988202,075203,330189,556190,171194,984194,963195,177191,163188,824189,767179,039188,049191,553195,025
Stockholders' Equity8,56910,39210,1739,57510,28510,64210,74910,8008,7889,36012,00612,58511,37811,79311,56314,18512,76212,0779,7179,84515,66415,96216,85316,04815,74015,18616,77616,96218,34019,807
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-12-312014-03-312014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2,1672,6852,3381,5042,4151,5742,6241,7811,2361,8831,7611,5951,8651,636-1,2601,307-5038021,7811,6941,4141,6241,5101,2384772,1122,901
Cost of Revenue
Gross Profit
R&D
SG&A
Tax100251-68022713532302103132-301031-886-150-766121567-719021-17699
Net Income21654531919498-4710465-754363609
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-12-312014-03-312014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating3903974735871,0254606168257739181,6894931,5924597454371,1778211,511409930621523558562
Cash Investing-4324311,165-2,616-651955-1,159260-2,760-568-2,298-61-1,797-2,292-8367,457-291-1,6089-1,793-882-1,143-1,436-1,021-1,643-2,845
Cash Financing30-1,036-1,0481,850408-2,4041,0962201,555-2991,432-1,0271,3931,526196-8,43195-2,634-1,6752575215197311481,3682,576